(Q33702647)

28 July 2017

1 reference

title

Hypoglycemia and insulin analogues: is there a reduction in the incidence? (English)

1 reference

28 July 2017

1 reference

Heinemann L

1

1 reference

28 July 2017

language of work or name

1 reference

1 March 1999

1 reference

Journal of Diabetes and its Complications

28 July 2017

published in

1 reference

28 July 2017

volume

13

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

105-114

1 reference

Towards more physiological insulin therapy in the 1990s. A comment

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Monomeric insulins and their experimental and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Comparison of insulin analogue B9AspB27Glu and soluble human insulin in insulin-treated diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Action profiles of fast onset insulin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Action profile of the rapid acting insulin analogue: human insulin B28Asp

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

1 reference

7 January 2021

Are presently available insulin analogues clinically beneficial?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Psychosocial state of patients with IDDM prone to recurrent episodes of severe hypoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

The relationship between symptomatic and biochemical hypoglycaemia in insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Improved mealtime treatment of diabetes mellitus using an insulin analogue. Multicenter Insulin Lispro Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Metabolic efficacy of preprandial administration of Lys(B28), Pro(B29) human insulin analog in IDDM patients. A comparison with human regular insulin during a three-meal test period.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Counterregulatory hormone responses after long-term continuous subcutaneous insulin infusion with lispro insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Intensified insulin therapy and the risk of severe hypoglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Effective and safe translation of intensified insulin therapy to general internal medicine departments

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Clinical outcomes with insulin lispro compared with human regular insulin: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Meal composition is a determinant of lispro-induced hypoglycemia in IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Early postprandial hypoglycemia following administration of lispro insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Symptomatic and physiological responses to hypoglycaemia induced by human soluble insulin and the analogue Lispro human insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900031-8

7 January 2021

10.1016/S1056-8727(99)00031-8

Identifiers

DOI

1 reference

28 July 2017

1 reference